Hidden thoughts under anesthesia: brain scans reveal possible awareness during sedation
NCT ID NCT07705022
First seen Jul 15, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study investigates whether mental activity—called covert consciousness—can occur during sedation with dexmedetomidine or ketamine. Healthy volunteers will undergo fMRI scans while performing mental imagery tasks (like imagining playing tennis) at different sedation depths. The goal is to understand how the brain functions when a person appears unresponsive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine (with propofol if needed) or ketamine
- What this could lead to
- If successful, this could reveal that some mental functions persist during anesthesia, potentially improving how sedation is monitored and managed.
- What could go wrong
- This is a small, early-phase study in healthy volunteers, so results may not apply to patients or real-world surgery. The mental imagery tasks may not fully capture consciousness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVERT CONSCIOUSNESS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test